Key facts
- Fatty15 supplement is now exclusively available on Fullscript.
- Fatty15 is a C15:0 supplement developed by Seraphina Therapeutics.
- Fullscript is described as a leading healthcare provider platform.
- The supplement is backed by over 100 peer-reviewed studies.
Seraphina Therapeutics, Inc., the company behind the Fatty15 supplement, has announced a new distribution strategy. The Fatty15 Advanced Formula Extra Strength, described as the first practitioner-exclusive C15:0 supplement, will now be available solely through the Fullscript platform. Fullscript is identified as the world's leading healthcare provider platform. The company emphasizes that the supplement is backed by more than 100 peer-reviewed studies.